Advanced Biomed Inc.
ADVB
$1.86
-$0.04-2.11%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -907.90K | -265.60K | -932.80K | -932.80K | -145.30K |
| Total Depreciation and Amortization | 99.10K | 102.20K | 52.80K | 52.80K | 73.40K |
| Total Amortization of Deferred Charges | -- | -- | 65.70K | 65.70K | -- |
| Total Other Non-Cash Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Change in Net Operating Assets | -33.00K | 133.70K | 43.60K | 43.60K | 106.30K |
| Cash from Operations | -841.80K | -29.70K | -770.70K | -770.70K | 34.30K |
| Capital Expenditure | 10.70K | -20.00K | -13.30K | -13.30K | -47.60K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 10.70K | -20.00K | -13.30K | -13.30K | -47.60K |
| Total Debt Issued | 425.10K | 409.30K | 321.30K | 321.30K | 701.50K |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -16.80K | -16.80K | 121.60K | 121.60K | -33.60K |
| Cash from Financing | 408.30K | 392.50K | 442.90K | 442.90K | 667.90K |
| Foreign Exchange rate Adjustments | 433.10K | -303.80K | 256.80K | 256.80K | -465.20K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 10.20K | 39.00K | -84.30K | -84.30K | 189.40K |